Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pharmacogenetics of the metabolic disturbances and atherosclerosis associated with antiretroviral therapy in HIV-infected patients.

Current pharmaceutical design - 1 Oct 2010

Veloso Sergi, Peraire Joaquim, Viladés Consuelo, López-Dupla Miguel, Escoté Xavier, Olona Montserrat, Garcia-Pardo Graciano, Gómez-Bertomeu Frederic, Soriano Antoni, Sirvent Joan-Josep, Vidal Francesc

Abstract excerpt

The availability of highly active antiretroviral therapy has markedly improved the survival rate and quality of life in patients infected with HIV. At present, however, there is still no cure for HIV and those undergoing treatment have to do so for life. The use of antiretroviral drugs has been associated with several toxicities that limit their success. Some acute and chronic toxicities associated with these...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-HIV Agents
Share to Antiretroviral Therapy, Highly Active

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Atherosclerosis

Share to Genetic Variation

Share to HIV Infections

Share to Insulin Resistance

Share to Metabolic Diseases

Share to Pharmacogenetics

Source

Identifiers

PMID: 20687887
DOI: 10.2174/138161210793563518

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pharmacogenetics of the metabolic disturbances and atherosclerosis associated with antiretroviral therapy in HIV-infected patients.PMID 20687887Read ↗

Pharmacogenetics of adverse effects due to antiretroviral drugs.Semantic proximity Read ↗

Pharmacogenetics of the lipodystrophy syndrome associated with HIV infection and combination antiretroviral therapy.Semantic proximity Read ↗

The toxicogenetics of antiretroviral therapy: the evil inside.Semantic proximity Read ↗

Dyslipidemia in HIV-infected individuals: from pharmacogenetics to pharmacogenomics.Semantic proximity Read ↗

Toxicogenetics of antiretroviral therapy: genetic factors that contribute to metabolic complications.Semantic proximity Read ↗

Pharmacogenetics of antiretroviral therapy.Semantic proximity Read ↗

Effect of genetic variations in drug transporters, metabolizing enzyme and regulatory genes on the development of HIV-associated lipodystrophy.Semantic proximity Read ↗

Pharmacogenetics of anti-HIV drugs.Semantic proximity Read ↗

Impact of genetic polymorphisms on the risk of lipid disorders in patients on anti-HIV therapy.Semantic proximity Read ↗

Pharmacogenomics of Antiretroviral Drug Metabolism and TransportSemantic proximity Read ↗

Association of Single Nucleotide Polymorphisms with Dyslipidemia in Antiretroviral Exposed HIV Patients in a Ghanaian populationSemantic proximity Read ↗

The dual role of pharmacogenetics in HIV treatment: mutations and polymorphisms regulating antiretroviral drug resistance and disposition.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.